Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Survey

December 31, 2018 updated by: Gynuity Health Projects
To determine if women can understand the instructions, carry out the test, and interpret the test results. Women will be recruited to complete a test instruction and comprehension assessment and a usability assessment.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

To determine if women can understand the instructions, carry out the test, and interpret the test results. Women will be recruited to complete a test instruction and comprehension assessment and a usability assessment. Study participants will be a convenience sample of women seeking health services. Participants will first be asked to review the instructions for the Congo Red Dot Test and complete a short written questionnaire that assesses their comprehension of the test instructions. Participants will then be asked to perform the test using a test control and to interpret the results obtained by answering a second written questionnaire. After the woman performs the test, a healthcare provider will use a matched control to perform a second test.

Study Type

Observational

Enrollment (Actual)

198

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mexico City, Mexico
        • Centro de Slaud Beatriz Velasco de Aleman

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 50 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Women attending Centre de Salud Beatriz Velasco de Aleman for health services

Description

Inclusion Criteria:

  • Eligible to consent for research
  • Able to read Spanish well enough to read the test instructions
  • Able to give informed consent

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Women
Women seeking health services will perform the Congo Red Dot test (GV-005) individually by following the the test instructions
The GV-005 is a simple test has been developed to detect unfolded or misfolded proteins in urine.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CRD Test Comprehension
Time Frame: within 5 minutes of reading test instructions
proportion of women who demonstrated various levels of understanding of the instructions for the CRD Test
within 5 minutes of reading test instructions

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CRD Test Usability
Time Frame: within 5 minutes of performing test
the proportion of women able to correctly use the CRD test
within 5 minutes of performing test

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2018

Primary Completion (Actual)

June 30, 2018

Study Completion (Actual)

December 30, 2018

Study Registration Dates

First Submitted

November 18, 2015

First Submitted That Met QC Criteria

November 18, 2015

First Posted (Estimate)

November 20, 2015

Study Record Updates

Last Update Posted (Actual)

January 3, 2019

Last Update Submitted That Met QC Criteria

December 31, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 4005B

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preeclampsia

Clinical Trials on Congo Red Test (GV-005)

Subscribe